Glucagon-like peptide-2 analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, 514 3, 530324, 530303, 530308, 435366, 435371, 935 52, 935 55, 935 66, 935 70, 935 71, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

057893799

ABSTRACT:
Analogs of glucagon-like peptide 2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical, and therapeutic use in treating disorders of the small bowel, are described.

REFERENCES:
Barragan, J.M.; Rodriguez, R.E.; and Blazquez, E. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. American Journal of Physiology. 266 (3 Pt 1), pE459-66, Mar. 1994.
Bloom, S.R. Gut Hormones in adaptation. Gut. 28, S1, pp. 31-35, 1987.
Brubaker, Patricia L. Regulation of Intestinal Proglucagon-Derived Peptide Secretion by Intestinal Regulatory Peptides. Endocrinology. vol. 128, No. 6, pp. 3175-3182, 1991.
Buhl, Thora; Thim, Lars; Kofod, Hans; Orskov, Catherine; Harling, Henrik; and Holst, Jens J. Naturally Occuring Products of Proglucagon 111-160 in the Porcine and Human Small Intestine. The Journal of Biological Chemistry. vol. 263, No. 18, pp. 8621-8624, Issue of Jun. 25, 1988.
Calvo, J.C., Yusta, B; Mora, F; and Blazquez, E. Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7-36) amide receptor in rat brain. J. Neurochem. 64(1), pp. 299-306, Jan. 1995.
Cheeseman, Chris I.; and Raymand Tsang. The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal basolateral membrane hexose transport. The American Physiological Society. APSracts 3:0071G, Apr. 16, 1996.
Drucker. Pancreas. 1990, 5(4):484.
Ehrlich, Peter; Tucker, Davin; Asa, Sylvia L.; Brubacker, Patricia L.; and Drucker, Daniel J. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors. American Journal of Physiology. pp. E662-E671, 1994.
George, S.K.; Uttenthal, L.O.; Ghiglione, M.; and Bloom, S.R. Molecular forms of glucagon-like peptides in man. FEBS Letters. vol. 192, No. 2, pp. 275-278, Nov. 1985.
Hoosein, Naseema M.; and Gurd, Ruth S. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Letters. vol. 178, No. 1, pp. 83-86, Dec. 1984.
Irwin, David M.; and Wong, Jaffe. Trout and Chicken Proglucagon: Alternative Splicing Generates mRNA Transcripts Encoding Glucagon-Like Peptide 2. Molecular Endocrinology. 9:267-277, 1995.
Lee, Ying C.; Asa, Sylvia L.; and Drucker, Daniel J. Glucagon Gene 5'-Flanking Sequences Direct Expression of Simian Virus 40 Large T Antigen to the Intestine, Producing Carcinoma of the Large Bowel in Transgenic Mice. The Journal of Biological Chemistry. vol. 267, No. 15, pp. 10706-10708, May 25, 1992.
Lund, P. Kay; Hoyt, Eileen; Simmons, James G.; and Ulshen, Martin H. Regulation of Intestinal Glucagon Gene Expression during Adaptive Growth of Small Intestine. Digestion . 54:371-373. 1993.
Mojsov, Svetlana; Heinrich, Gerhard; Wilson, Ira B.; Ravazzola, Mariella; Orci, Lelio; and Habener, Joel F. Preproglucagon Gene Expression in Pancreas and Intestine Diversifies at the Level of Post-translational Processing. The Journal of Biological Chemistry. vol. 261, No. 25, pp. 11880-11889, Sep. 5, 1986.
Mommsen, Thomas P., Andrews, P.C.; and Plisetskaya, Erika M. Glucagon-like peptides activate hepatic gluconeogenesis. FEBS Letters. vol. 219, No. 1, pp. 227-232, Jul. 1987.
Nishi and Steiner, Mol. Endocrinol., 1990, 4:1192-8.
Orskov, C.; Buhl, T.; Rabenhoj, L.; Kofod, H.; and Holst, J.J.. Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS Letters. 247(2), pp. 193-196, Apr. 24, 1989.
Orskov, C.; Holst, J.J.; Pouisen, S. Seier; and Kirkegaard, P. Pancreatic and Intestinal processing of proglucagon in man. Diabetologia. 30:874-881, 1987.
Orskov, C.; and Holst, J.J. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand. J. Clin. Lab. Invest. 47(2), pp. 165-174, Apr. 1987.
Orskov, Catherine; Holst, Jens J.; Knuhtsen, Svend; Baldissera, Furio G.A.; Poulsen, Steen S.; and Nielsen, O. Vagn. Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas. Endocrinology. vol. 119, No. 4, pp. 1467-1475, 1986.
Ruiz-Grand, C., Pintado, J.; Alarcon, C.; Castilla, C.; Valverde, I; Lopez-Novoa, J.M. Renal catabolism of human glucagon-like peptides 1 and 2. Can. J. Physiol. Pharmacol. 68(12), pp. 1568-1573, Dec. 1990.
Shennan, K.I.J.; Holst, J.J.; and Docherty, K. Proglucagon expression, posttranslational processing and secretion in SV40-transfromed islet cells. Molecular and Cellular Endocrinology. 67(1989), pp. 93-99.
Watanabe, Nobuaki; Matsuyama, Tatsuo; Namba, Mitsuyoshi; Miyagawa, Jun-ichiro; Itoh, Hidehiko; Komatsu, Ryoya; Kono, Norio; and Tarui, Seiichiro. Trophic Effect of Glucagon-(1-21)-Peptide on the Isolated Rat Ileal Mucosal Cells. Biochemical and Biophysical Research Communications. vol. 152, No. 3, pp. 1038-1044, May 16, 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Glucagon-like peptide-2 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon-like peptide-2 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon-like peptide-2 analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1177204

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.